Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis
NCT01326741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2011-03-31
Summary
Anaphylaxis is a serious allergic reaction that develops rapidly and can cause death. Some patients experience anaphylaxis is association with exercise, a disorder called exercise-induced anaphylaxis. A subset of patients with unexplained anaphylaxis, especially those with hypotension during the anaphylactic episodes, have been shown to have abnormal, clonal populations of a certain cell type, mast cells, in the bone marrow. This has been described in at least one patient with exercise-induced anaphylaxis. The investigators would like review the findings in a group of patients with exercise-induced anaphylaxis who have undergone evaluation for the presence of abnormal, clonal mast cells.
Conditions
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
NCT00557895 ·Status: TERMINATED
-
Mechanisms of Anaphylaxis
NCT03182491 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Basis of Food Allergy
NCT01832324 ·Status: ENROLLING_BY_INVITATION
-
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
NCT05210543 ·Status: RECRUITING
-
7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis
NCT00115089 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Effects of Various Aerobic Exercise in Allergic Rhinitis.
NCT05707611 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients
NCT02461797 ·Status: COMPLETED ·Phase: NA
-
The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
NCT02214303 ·Status: UNKNOWN
-
Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction
NCT05135377 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Cetirizine HCl on Exercise-induced Arterial Hypoxemia in Highly-trained Swimmers
NCT05095311 ·Status: TERMINATED ·Phase: PHASE4
-
Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.
NCT04622917 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients
NCT02123914 ·Status: COMPLETED ·Phase: NA
-
Role of the Central Nervous System in Allergic Rhinitis
NCT01777464 ·Status: TERMINATED ·Phase: NA
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
NCT00091871 ·Status: RECRUITING
-
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
NCT01378429 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)
NCT00261287 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effect of High Intensity Interval Exercise in Patients With Allergic Rhinitis
NCT05779046 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
Effect of Montelukast on Basophils, In-vitro
NCT00710450 ·Status: UNKNOWN
-
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
NCT01318954 ·Status: COMPLETED
-
Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis
NCT00988247 ·Status: COMPLETED ·Phase: PHASE3
-
Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy
NCT02194530 ·Status: COMPLETED
-
Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.
NCT01134757 ·Status: COMPLETED ·Phase: NA